Recently a noncanonical activity of autophagy proteins has been discovered that targets lipidation of microtubule-associated protein 1 light chain 3 (LC3) onto macroendocytic vacuoles, including macropinosomes, phagosomes, and entotic vacuoles. While this pathway is distinct from canonical autophagy, the mechanism of how these nonautophagic membranes are targeted for LC3 lipidation remains unclear. Here we present evidence that this pathway requires activity of the vacuolar-type H(+)-ATPase (V-ATPase) and is induced by osmotic imbalances within endolysosomal compartments. LC3 lipidation by this mechanism is induced by treatment of cells with the lysosomotropic agent chloroquine, and through exposure to the Heliobacter pylori pore-forming toxin VacA. These data add novel mechanistic insights into the regulation of noncanonical LC3 lipidation and its associated processes, including LC3-associated phagocytosis (LAP), and demonstrate that the widely and therapeutically used drug chloroquine, which is conventionally used to inhibit autophagy flux, is an inducer of LC3 lipidation.
- Bacterial Proteins
- Cell Line
- Microtubule-Associated Proteins
- Phosphatidylinositol Phosphates
- Vacuolar Proton-Translocating ATPases
FingerprintDive into the research topics of 'V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation'. Together they form a unique fingerprint.
- Deanery of Molecular, Genetic and Population Health Sciences - Chancellor's Fellow
- Edinburgh Cancer Research Centre
Person: Academic: Research Active